Clinical Study of U32 in Patients With Acute Myeloid Leukemia

NCT07036250 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukaemia

Interventions

DRUG: U32 CAR-T

Sponsor

Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd